DietREACHNCT05472454
The Ready-to-Eat Meals for Cardiovascular Health Study
A study testing Ready-to-eat meals in people with Diet and Hypertension, run by Washington State University at 1 site in United States.
Trial summary
The proposed project explores the acceptability and health benefits of ready-to-eat (RTE) meals based on the Dietary Approaches to Stop Hypertension (DASH) eating plan. The researchers have developed 14 recipes following the DASH eating plan, which is recommended for the prevention of cardiovascular disease (CVD). Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Diet, Hypertension, Cardiovascular Diseases
- What is being tested?
- Ready-to-eat meals
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 20 participants
- Where
- 1 siteUnited States
- Study dates
- 7 Oct 2022to 1 May 2023
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Male or female
- 18 years old or older
- BMI 18.5-40.0 kg/m2
- Daily access to working internet, microwave, refrigerator, and freezer
- English fluency
Who cannot join
- Regular use of drugs that affect BP, including weight loss medications
- Diagnosed hypertension OR systolic BP >130 and/or diastolic BP >80
- Diagnosis of any hypotensive disorders OR systolic BP <100 and/or diastolic BP<65
- Dietary restrictions, including allergy/intolerances
- Presence or history of diabetes
- Previous cardiac event, congestive heart failure, or angina
Show all 16Show fewer
- Weight loss or gain>15lb in previous 3 months
- Following a diet to increase or decrease body weight
- Cancer diagnosis or treatment in past 2 years
- ≥14 alcoholic drinks/week for men; ≥ 7 alcoholic drinks/week for women
- Use of nicotine, marijuana, or illicit drugs
- Pregnancy, planned pregnancy, or breastfeeding
- Inability to comprehend the nature of the study or instructions
- No access to the internet
- Planning to leave the Spokane area during the study
- Not fluent in the English language
Trial locations and contacts
1 site in 1 country.
United States1 site
Washington State University
Spokane, Washington, 99202
About this study
Official title: The Ready-to-EAt Meals for Cardiovascular Health (REACH) Study
The proposed project explores the acceptability and health benefits of ready-to-eat (RTE) meals based on the Dietary Approaches to Stop Hypertension (DASH) eating plan. The researchers have developed 14 recipes following the DASH eating plan, which is recommended for the prevention of cardiovascular disease (CVD). The prepackaged meals will be processed using Washington State University (WSU) microwave technologies to ensure food safety. In this pilot study, a sample of 30 participants will be recruited by to study the impact of the DASH meals on blood pressure. All meals will be provided to participants, who will consume the meals daily over a period of 4 weeks. Daily and weekly monitoring of participants (blood pressure and weight) will allow us to gain a scientific understanding on the preventive power of healthy diets in lowering blood pressure and reducing CVD risk.
- Conditions
- Diet, Hypertension, Cardiovascular Diseases, Blood Pressure
- Being tested
- Ready-to-eat meals
- Keywords
- DASH, Dietary Approaches to Stop Hypertension, Meals, High Blood Pressure, Hypertension
- Medical subject headings
- Hypertension, Cardiovascular Diseases
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Ready-to-eat mealsOther
Participant group to consume ready-to-eat meals in accordance with the DASH diet for a period of 4 weeks.
| Study group | Role | What they receive |
|---|---|---|
| Ready-to-eat meals | Other | Pre-Post Receives: Other: Ready-to-eat meals |
What is being measured
The primary outcome is the main question the study is designed to answer.
Blood pressure
To determine dietary patterns on blood pressure using an omron blood pressure monitor.
Measured: through study completion, measured weekly for 5 weeks
Secondary outcomes (1)
Body weight (kg)
To determine dietary patterns on body weight (kg) using a Angel USA 400 Pound Physician Digital Scale.
Measured: through study completion, measured weekly for 5 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted25 Jul 2022
- Study start7 Oct 2022
- Primary completion1 May 2023
- Study completion1 May 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for DietStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Not applicable
- Intervention model
- Single group
- Model description
- Pre-post design
- Masking
- None (open label)
- Enrolment
- 20 participants (actual)
Sponsor and investigators
- Lead sponsor
- Washington State University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Pablo Monsivais, Washington State University
- Investigators
- Pablo Monsivais, PhD, MPH, Principal investigator, Washington State UniversityMartine M Perrigue, PhD, RDN, Principal investigator, Washington State UniversityCatherine Jarrett, PhD, RDN, Principal investigator, Washington State University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05472454
- Sponsor's protocol ID
- 19288-001
- Acronym
- REACH
- Status last verified
- Jun 2026
- First submitted
- 15 Jul 2022
- Last updated
- 3 Jun 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 3 Jun 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Ready-to-EAt Meals for Cardiovascular Health (REACH) Study
- ClinicalTrials.gov ID
- NCT05472454
- Acronym / sponsor ID
- REACH / 19288-001
- Conditions
- Diet, Hypertension, Cardiovascular Diseases, Blood Pressure
- Keywords
- DASH, Dietary Approaches to Stop Hypertension, Meals, High Blood Pressure, Hypertension
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 20 participants (actual)
- Lead sponsor
- Washington State UniversityUniversity, hospital or other
- Study start
- 7 Oct 2022 (actual)
- Primary completion
- 1 May 2023 (actual)
- Study completion
- 1 May 2023 (actual)
- First posted
- 25 Jul 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The proposed project explores the acceptability and health benefits of ready-to-eat (RTE) meals based on the Dietary Approaches to Stop Hypertension (DASH) eating plan. The researchers have developed 14 recipes following the DASH eating plan, which is recommended for the prevention of cardiovascular disease (CVD). The prepackaged meals will be processed using Washington State University (WSU) microwave technologies to ensure food safety. In this pilot study, a sample of 30 participants will be recruited by to study the impact of the DASH meals on blood pressure. All meals will be provided to participants, who will consume the meals daily over a period of 4 weeks. Daily and weekly monitoring of participants (blood pressure and weight) will allow us to gain a scientific understanding on the preventive power of healthy diets in lowering blood pressure and reducing CVD risk.
Study design
- Primary purpose
- Prevention
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
- Model description
- Pre-post design
| Arm | Type | Receives |
|---|---|---|
| Ready-to-eat meals | Other | Other: Ready-to-eat mealsPre-Post |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (5 listed)
- Male or female
- 18 years old or older
- BMI 18.5-40.0 kg/m2
- Daily access to working internet, microwave, refrigerator, and freezer
- English fluency
Key exclusion criteria (16 listed)
- Regular use of drugs that affect BP, including weight loss medications
- Diagnosed hypertension OR systolic BP >130 and/or diastolic BP >80
- Diagnosis of any hypotensive disorders OR systolic BP <100 and/or diastolic BP<65
- Dietary restrictions, including allergy/intolerances
- Presence or history of diabetes
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Ready-to-eat mealsParticipant group to consume ready-to-eat meals in accordance with the DASH diet for a period of 4 weeks. | Other | Ready-to-eat meals |
Primary outcome
Blood pressure
Time frame: through study completion, measured weekly for 5 weeks
To determine dietary patterns on blood pressure using an omron blood pressure monitor.
1 secondary outcome
Body weight (kg)
Time frame: through study completion, measured weekly for 5 weeks
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 3 Jun 2026.
- Individual participant dataSharing planned: No
Related trials for Diet
Active, not recruiting
A Pilot Factorial Trial of an Integrated Lifestyle Intervention
Physical Inactivity, Overweight and Obesity
Not yet recruiting
A Study on the Addition of Alsum30 for the Treatment of Amyotrophic Lateral Sclerosis
Amyotrophic Lateral Sclerosis (ALS), Bacillus Coagulans
Recruiting
Short-Term Reduced Dietary Protein in ER+/HER2- Breast Cancer Patients During Neoadjuvant Chemotherapy
Breast Cancer, Hormone Receptor Positive / HER2-negative Breast Cancer
Not yet recruiting
Testing a Smartphone App to Support a Mediterranean Diet and Strength Exercise
Treatment Adherence and Compliance, Resistance Exercise
Not yet recruiting
Effects of Ad Libitum Ultra-Processed Diet on Brain Dopamine in Humans
Healthy Volunteers
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Pablo Monsivais, PhD, MPH principal investigator
Washington State University
Martine M Perrigue, PhD, RDN principal investigator
Washington State University
Catherine Jarrett, PhD, RDN principal investigator
Washington State University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Ready-to-eat meals in people with Diet and Hypertension, run by Washington State University at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 16 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 3 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Blood pressure (time frame: through study completion, measured weekly for 5 weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Jun 2026.